SQZ Biotechnologies is a biotechnology company developing cell therapies for patients with cancer and other serious conditions. In oncology, Co. is developing cell therapy platforms that are based on directing tumor antigen-specific immune activation via engineered antigen presentation. Co.'s product candidate pipeline includes: SQZ® Enhanced Antigen Presenting Cell Platform, which is designed to generate tumor-specific CD8+ T cell activation to drive the antitumor immune response; and SQZ® Activating Antigen Carrier Platform, which is designed to induce antigen presentation in vivo by deriving antigen carriers from engineering red blood cells with tumor-specific antigens and adjuvant. We show 10 historical shares outstanding datapoints in our SQZ shares outstanding history coverage, used to compute SQZ market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SQZ market cap history over the course of time is important for investors
interested in comparing SQZ's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SQZ versus a peer is one thing; comparing
SQZ market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SQZ can fluctuate over the course of history.
With this page we aim to empower investors researching SQZ by allowing them to research the SQZ market cap history. |
Free SQZ Email Alerts:
Video: The Importance of Market Cap
